Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin‐Induced Nephrotoxicity

20260 citationsJournal Articlehybrid Open Access

Authors

Yoshihiko MATSUKI · Teikyo University

Ken‐ichi Sako · Nihon Pharmaceutical University

Y. Kozima · Chiba-Nishi General Hospital

Tamaki Watanabe · Teikyo University Hospital

Yasuharu Kashiwagura · Teikyo University

Nobuhiro Yasuno · Teikyo University Hospital

Shigekazu Watanabe ·

Abstract

The scoring model developed in the present study may enhance risk stratification for VCM-induced nephrotoxicity and contribute to advances in individualized dosing strategies in clinical practice.

Topics & Keywords

Antimicrobial Resistance in Staphylococcus Antibiotics Pharmacokinetics and Efficacy Pharmacovigilance and Adverse Drug Reactions

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

Volume 46, Issue 2, pp. e70111-e70111

DOI: 10.1002/phar.70111

Field-Weighted Citation Impact: 0.00